Chronic Atrophic Scar-like Plaque: Challenge

2022 ◽  
Vol 44 (1) ◽  
pp. e6-e7
Author(s):  
Mohamed H. M. El-Komy ◽  
Yousra Azzazi ◽  
Rofaida El Naggar ◽  
Mona R. E. Abdel-Halim
Keyword(s):  
Atrophic Scar

Choroidal neovascularisation triggered multiple evanescent white dot syndrome (MEWDS) in predisposed eyes

2017 ◽  
Vol 102 (7) ◽  
pp. 971-976 ◽  
Author(s):  
Thibaud Mathis ◽  
Benoit Delaunay ◽  
Armelle Cahuzac ◽  
Vivien Vasseur ◽  
Martine Mauget-Faÿsse ◽  
...  
Keyword(s):  
Case Series ◽  
Congenital Toxoplasmosis ◽  
Acute Onset ◽  
Functional Responses ◽  
Retinal Tissue ◽  
White Dot Syndrome ◽  
Atrophic Scar ◽  
The Mean ◽  
Endothelial Growth Factor

BackgroundMultiple evanescent white dot syndrome (MEWDS) is an inflammatory disease that can be associated with choroidalneovascularisation (CNV). However, few studies in the literature have described the occurrence of MEWDS in association with CNV. This paper discusses whether CNV can trigger MEWDS in a predisposed eye.MethodsA retrospective multicentric case series of six eyes in six patients with acute onset of MEWDS and evidence of previous CNV was conducted between January 2015 and January 2017. All patients underwent ophthalmic examination including multimodal imaging at baseline and during follow-up.ResultsThe mean age was 32.2±12.2 years. The majority of patients were women (5/1). In each case, MEWDS was diagnosed during a recurrence or occurrence of CNV secondary to choriocapillaritis, central serous chorioretinopathy or atrophic scar, presumably due to congenital toxoplasmosis. All patients were treated with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) with good anatomical and functional responses (mean gain of 0.3±0.31logMAR). The mean duration of follow-up was 13.5±10.65 months.ConclusionThis study highlights a sequence in the development of MEWDS, following the occurrence or recurrence of CNV. CNV may trigger MEWDS, possibly due to the proinflammatory environment created by the retinal tissue surrounding the CNV.

Quantification of scar margin in keloid different from atrophic scar by multiphoton microscopic imaging

Scanning ◽  
2011 ◽  
Vol 33 (4) ◽  
pp. 195-200 ◽  
Author(s):  
Xiaoqin Zhu ◽  
Shuangmu Zhuo ◽  
Liqin Zheng ◽  
Xingshan Jiang ◽  
Jianxin Chen ◽  
...  
Keyword(s):  
Microscopic Imaging ◽  
Atrophic Scar

Successful Treatment of Atrophic Scars from Cutaneous Leishmaniasis Using a Fractional Laser

2010 ◽  
Vol 14 (6) ◽  
pp. 303-306 ◽  
Author(s):  
Khalid M. AlGhamdi
Keyword(s):  
Cutaneous Leishmaniasis ◽  
Successful Treatment ◽  
Treatment Options ◽  
Treatment Modalities ◽  
Fractional Laser ◽  
Atrophic Scar ◽  
Atrophic Scars ◽  
Skin Conditions ◽  
Excellent Improvement

Background: Cutaneous leishmaniasis can lead to unsightly atrophic scars, which have limited treatment options. There is a scarcity of literature on its treatment modalities. Fractional lasers have been successfully used in treating a variety of skin conditions with minimal downtime and side effects. Methods: We report a successful treatment of a 25-year-old female patient with an atrophic scar from cutaneous leishmaniasis on the nose with a fractional laser (Fraxel Re:store SR 1500). Ten treatment sessions were performed at a pulse energy of 45 to 70 mJ. The treatment response was assessed by comparing pre- and posttreatment clinical photographs. Results: After three sessions, the patient observed 40% improvement. More than 90% improvement was noticed after the tenth session. No significant adverse effects were noted. The improvement was persistent at the 3-month follow-up. Conclusion: The excellent improvement in this patient should encourage further studies to achieve more efficacy and optimize the treatment parameters.

scholarly journals Squamous cell carcinoma in an atrophic scar of Porphyria Cutanea Tarda

2019 ◽  
Vol 5 (4) ◽  
pp. 349-352
Author(s):  
Gosavi AP ◽  
◽  
Chavan RB ◽  
Belgaumkar VA ◽  
Deshmukh NS ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Porphyria Cutanea Tarda ◽  
Atrophic Scar

scholarly journals Platelet Rich Plasma: Is it Effective in Treatment of Atrophic Scar?

2018 ◽  
Vol 42 (2) ◽  
pp. 251-258
Author(s):  
Hafsa Mohamed ◽  
Ahmed Kamal ◽  
Heba Saad El Deen ◽  
Mahmoud El Oteify
Keyword(s):  
Platelet Rich Plasma ◽  
Atrophic Scar

scholarly journals Juvenile Xanthogranuloma

2020 ◽  
Vol 2 (1) ◽  
pp. 52-57
Author(s):  
Irma Primawati
Keyword(s):  
Mucous Membrane ◽  
Langerhans Cells ◽  
Lower Extremities ◽  
Male Infant ◽  
Giant Cells ◽  
The Other ◽  
Juvenile Xanthogranuloma ◽  
Systemic Involvement ◽  
Upper And Lower Extremities ◽  
Atrophic Scar

Juvenile xanthogranuloma is the most common form of non-Langerhans-cells histiocytosis or non-X histiocytosis. Most often affecting infants and young children.A case of  juvenile xanthogranuloma in a 3-month-old male infant has been reported. There were multiple, discrete, firm, red-brownish, orange nodules, round and oval in shape, well-defined, 0.5–2 cm in diameter, disseminated on his scalp, face, trunk, upper and lower extremities, also genitalia and some of them with ulceration on its surface. No mucous membrane and systemic involvement. Pathology result revealed Touton giant cells that characteristic to juvenile xanthogranuloma although the other diseases might contain these cells such as Hashimoto-Pritzker disease and dermatofibroma. Within few years, the lesions could regression spontaneously and leaving a flat, atrophic scar or an area of altered pigmentation.

Sign in / Sign up

Export Citation Format

Share Document